China Money Network
Login
Join

Sequoia China Leads $80M Pre-IPO Round In Chinese Biotech Firm

  • January 7, 2019 — 14:01 CST

This Data Is Locked!

This area is available only to Subscribers.

BrightGene Bio-Medical Technology Co., a Chinese biopharmaceutical company, has received RMB550 million (US$80.06 million) in a pre-IPO round of financing, led by Sequoia China and... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: